MiMedx Inc.: Initial Assessment by Citizens JMP Two Days Before the Numbers with 93% Price Potential - Is a Positive Surprise on the Horizon?

MiMedx Inc. (MDXG) manufactures proprietary biologics and skin substitute products for the treatment of chronic wounds (such as diabetic foot ulcers). To understand MiMedx, one must first look at the problem they are solving. Most of us get a cut or scrape, put on a regular band-aid, and the body heals itself in a few days. However, for many people – particularly older patients or those with severe diabetes – this natural healing process no longer works properly. They suffer from so-called chronic wounds (such as "diabetic foot syndrome”)....